Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting

Liver Transpl. 2024 Nov 1;30(11):1181-1187. doi: 10.1097/LVT.0000000000000409. Epub 2024 May 28.

Abstract

Liver transplantation (LT) is the most successful treatment for patients with decompensated cirrhosis. The availability of effective and safe etiological treatments has altered the natural history of decompensated cirrhosis. Recently, the concept of recompensation has been defined. Patients who achieve recompensation may be removed from the waiting list for LT. Therefore, achieving an etiological cure is the cornerstone in the treatment of patients with decompensated cirrhosis. However, most patients improve their liver function after an etiologic cure, and only a proportion of patients achieve true recompensation after an etiological cure. Some patients maintain a condition of "MELD purgatory," that is, an improvement in the Model for End-Stage Liver Disease score without relevant clinical improvement that prevents delisting and may be even detrimental because lower Model for End-Stage Liver Disease score delays LT. Herein, we review the available evidence regarding recompensation and the management of recompensated patients on the waiting list for LT.

Publication types

  • Review

MeSH terms

  • End Stage Liver Disease* / surgery
  • Humans
  • Liver Cirrhosis* / complications
  • Liver Cirrhosis* / surgery
  • Liver Transplantation* / adverse effects
  • Liver Transplantation* / methods
  • Patient Selection
  • Severity of Illness Index
  • Treatment Outcome
  • Waiting Lists*